Products for Research Use Only

Estradiol enanthate

CAT: 0804-HY-B1830-01Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B1830-01Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Estradiol enanthate (E2EN) is a shorter-acting estrogen. Estradiol enanthate is an injectable contraceptive in combination with Dihydroxyprogesterone acetophenide. Estradiol enanthate promotes withdrawal bleeding, in a pattern similar to menstruation[1].
CAS Number
4956-37-0
Product Name Alternative
E2EN
UNSPSC
12352005
Hazard Statement
H351, H361
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/estradiol-enanthate.html
Concentration
10mM
Purity
99.41
Solubility
DMSO : 125 mg/mL (ultrasonic) |Ethanol : ≥ 100 mg/mL
Smiles
C[C@@]12[C@@H](OC(CCCCCC)=O)CC[C@@]1([H])[C@]3([H])CCC4=C(C=CC(O)=C4)[C@@]3([H])CC2
Molecular Formula
C25H36O3
Molecular Weight
384.55
Precautions
H351, H361
References & Citations
[1]Elsimar M. Coutinho, et al., Comparison of two regimens of a monthly injectable contraceptive containing dihydroxyprogesterone acetophenide and estradiol enanthate, Contraception, Volume 73, Issue 3, 2006, Pages 249-252, ISSN 0010-7824. |[2]Gusmão-Silva, J. V., et al., (2022) . Body, metabolic and renal changes following cross-sex estrogen/progestogen therapy in a rodent model simulating its use by transwomen. Journal of endocrinological investigation, 45 (10), 1875–1885.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported